Agilysys, Inc. (NASDAQ:AGYS – Get Free Report) has received a consensus rating of “Buy” from the six research firms that are currently covering the stock, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $134.80.
Several equities research analysts recently issued reports on AGYS shares. BTIG Research raised their price objective on shares of Agilysys from $118.00 to $124.00 and gave the stock a “buy” rating in a research report on Tuesday, October 29th. Oppenheimer lifted their price target on shares of Agilysys from $120.00 to $135.00 and gave the company an “outperform” rating in a research report on Tuesday, November 12th. Needham & Company LLC lifted their price target on shares of Agilysys from $125.00 to $145.00 and gave the company a “buy” rating in a research report on Friday, November 15th. Northland Securities reiterated an “outperform” rating and set a $145.00 price target (up from $132.00) on shares of Agilysys in a research report on Tuesday, October 29th. Finally, StockNews.com cut shares of Agilysys from a “buy” rating to a “hold” rating in a research report on Thursday, October 31st.
Get Our Latest Stock Report on AGYS
Insider Activity at Agilysys
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its stake in Agilysys by 162.1% in the second quarter. GAMMA Investing LLC now owns 249 shares of the software maker’s stock worth $26,000 after acquiring an additional 154 shares during the last quarter. CWM LLC lifted its stake in Agilysys by 390.2% in the second quarter. CWM LLC now owns 250 shares of the software maker’s stock worth $26,000 after acquiring an additional 199 shares during the last quarter. Larson Financial Group LLC purchased a new position in Agilysys in the second quarter worth approximately $32,000. Advisors Asset Management Inc. lifted its stake in Agilysys by 117.4% in the third quarter. Advisors Asset Management Inc. now owns 337 shares of the software maker’s stock worth $37,000 after acquiring an additional 182 shares during the last quarter. Finally, NBC Securities Inc. purchased a new position in Agilysys in the third quarter worth approximately $46,000. Hedge funds and other institutional investors own 88.00% of the company’s stock.
Agilysys Price Performance
Agilysys stock opened at $133.89 on Thursday. Agilysys has a 12-month low of $73.52 and a 12-month high of $139.99. The stock has a market cap of $3.74 billion, a P/E ratio of 38.15 and a beta of 0.85. The company has a 50-day moving average price of $114.75 and a 200 day moving average price of $107.15. The company has a current ratio of 1.13, a quick ratio of 1.07 and a debt-to-equity ratio of 0.19.
Agilysys (NASDAQ:AGYS – Get Free Report) last released its quarterly earnings data on Monday, October 28th. The software maker reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.04. Agilysys had a net margin of 37.54% and a return on equity of 10.53%. The firm had revenue of $68.30 million during the quarter, compared to analysts’ expectations of $67.54 million. During the same period last year, the business earned $0.25 earnings per share. Agilysys’s revenue was up 16.6% compared to the same quarter last year. Sell-side analysts anticipate that Agilysys will post 0.81 earnings per share for the current year.
About Agilysys
Agilysys, Inc operates as a developer and marketer of software-enabled solutions and services to the hospitality industry in North America, Europe, the Asia-Pacific, and India. It offers software solutions fully integrated with third party hardware and operating systems; cloud applications, support, and maintenance; subscription and maintenance; and professional services.
See Also
- Five stocks we like better than Agilysys
- How to Use the MarketBeat Dividend Calculator
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- The How and Why of Investing in Gold Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Agilysys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilysys and related companies with MarketBeat.com's FREE daily email newsletter.